A clinical trial to investigate cemsidomide monotherapy in later lines of therapy in peripheral T-cell lymphoma (PTCL)
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Cemsidomide (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 21 Jan 2025 New trial record
- 14 Jan 2025 According to C4 Therapeutics media release, this study is expected to initiate in early 2026.